Beijing Cotimes Biotech Co. Ltd.

Calculating rank

USPTO Granted Patents = 4

% Expired Patents = 75.0

EPO Patents = 1

Forward Citations = 3

Loading Chart...

9 inventors (with patents filed for the assignee):

Enyun Shen (4 out of 6 patents)

Shiqi Ren (2 out of 3 patents)

Yang Song (2 out of 32 patents)

4. Min Zhou (1 out of 23 patents)

5. Zheng Yu (1 out of 139 patents)

6. Fei Guo (1 out of 19 patents)

7. Tong Zhou (1 out of 29 patents)

8. Xian Chen (1 out of 3 patents)

9. Donald J Buchsbaum (1 out of 19 patents)

4 patents: Sort by Forward Citations

1. 9840551 - Blood markers for diagnosing epithelium derived cancers and monoclonal antibodies thereof (2017-12-12),

2. 9637543 - HER3 antibodies and uses thereof (2017-05-02),

3. 9255142 - Blood markers for diagnosing epithelium derived cancers and monoclonal antibodies thereof (2016-02-09),

4. 8367356 - Gelsolin binding agent compositions and uses of same (2013-02-05),

Company Overview

Beijing Cotimes Biotech Co. Ltd. is a leading biotechnology company specializing in the research, development, and production of innovative biopharmaceuticals. With a team of talented scientists and state-of-the-art facilities, the company is dedicated to improving human health and quality of life through cutting-edge biotech solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#559 in Beijing

#6,444 in China

Beijing, China

Beijing Cotimes Biotech Co. Ltd.

Forward Citations = 3

9 inventors:

Enyun Shen (4 out of 6 patents)

Shiqi Ren (2 out of 3 patents)

Yang Song (2 out of 32 patents)

4. Min Zhou (1 out of 23 patents)

5. Zheng Yu (1 out of 139 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Beijing Cotimes Biotech Co. Ltd.. Retrieved from https://idiyas.com/company/beijing-cotimes-biotech-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]